Successful prolonged use of recombinant human insulin-like growth factor-1 in a child with cystic fibrosis.
Pediatr Pulmonol
; 46(11): 1137-41, 2011 Nov.
Article
in En
| MEDLINE
| ID: mdl-21618713
ABSTRACT
Growth failure is a common and complicated process in children with cystic fibrosis (CF). Growth hormone, which is becoming a more commonly used agent in such patients, has demonstrated beneficial effects aside from increased growth velocity. Recently, insulin-like growth factor-1 has gained significant attention in the understanding of growth failure in children with CF. We report the successful prolonged use of recombinant human insulin-like growth factor-1 in an adolescent boy with CF, who demonstrated significant clinical benefits from the therapy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Proteins
/
Insulin-Like Growth Factor I
/
Cystic Fibrosis
/
Failure to Thrive
Limits:
Adolescent
/
Humans
/
Male
Language:
En
Journal:
Pediatr Pulmonol
Journal subject:
PEDIATRIA
Year:
2011
Document type:
Article
Affiliation country: